Food And Drug Administration rejects Avastin to be used against metastatic cancer of the breast. “We found after rigorous screening the medial side aftereffects of Avastin were more harmful compared to advantages,” Hamburg said.

Food And Drug Administration rejects Avastin to be used against metastatic cancer of the breast. “We found after rigorous screening the medial side aftereffects of Avastin were more harmful compared to advantages,” Hamburg said. The foodstuff and Drug management...